Search alternatives:
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
781
-
782
-
783
-
784
-
785
Determination of minimum fungicidal concentration of WSWE against <i>S</i>. <i>globosa</i>.
Published 2022Subjects: -
786
-
787
Micromorphological impact of WSWE treatment on <i>S</i>. <i>globosa</i> cells.
Published 2022Subjects: -
788
-
789
WSWE treatment reduced total ergosterol amount in <i>S</i>. <i>globosa</i> cells.
Published 2022Subjects: -
790
Decrease of NF-κB activity in tumor tissue of CCR5<sup>−/−</sup> mice.
Published 2013“…<b>C</b>, Immunolfluorescence analysis of p50 confirmed that the intensities of nuclear staining for p50 were decreased in the tumor tissues of CCR5<sup>−/−</sup> mice. …”
-
791
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
Published 2018“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”
-
792
Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer
Published 2016“…Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2–5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2–0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. …”
-
793
-
794
Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice
Published 2011“…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
-
795
-
796
-
797
-
798
-
799
-
800